Fenchone

Fenchone at a Glance

Fenchone is a bitter, camphoraceous bicyclic monoterpene ketone of fennel, and a minor component of some wormwood and cedar oils — the compound behind fennel’s sharper, slightly medicinal edge, as distinct from anethole’s sweetness.

It is GRAS as a flavouring, with modest preclinical spasmolytic, antimicrobial and antioxidant activity.

Fenchone Is Not Thujone

Fenchone shares a bottle with thujone in Thuja and wormwood oils, a camphor-like smell, and the words “monoterpene ketone” — and that is where the resemblance ends. The distinction matters because thujone’s reputation is fenchone’s biggest liability.

	Fenchone	Thujone	Camphor
Skeleton	bicyclo[2.2.1]heptane (a norbornane, like camphor)	bicyclo[3.1.0]hexane, with a strained cyclopropane ring	bicyclo[2.2.1]heptane
GABA-A receptor	no antagonism reported	a GABA-A antagonist; convulsant at high dose	weak; convulsant at overdose
Metabolism	hydroxylation by CYP2A6/2B6 to 6- and 10-hydroxyfenchone; no reactive metabolite ^{8,9Reference 8Miyazawa M · 2006In vitroMetabolism of (+)-fenchone by CYP2A6 and CYP2B6 in human liver microsomes — in vitroView study →Reference 9Miyazawa M · 2007In vitroMetabolism of (-)-fenchone by CYP2A6 and CYP2B6 in human liver microsomes — in vitroView study →}	oxidation with a neurotoxic profile at dose	hydroxylation
Regulatory status	GRAS flavouring; RIFM: safe at current fragrance use ^{13Reference 13Api AM et al. · 2025ReviewUpdate to RIFM fragrance ingredient safety assessment, fenchone, CAS Registry Number 1195-79-5 — safety reviewView study →}	limited in foods and spirits by law	limited in foods
Where it dominates	bitter fennel, French lavender	wormwood, sage, Thuja	camphor laurel, rosemary

Fenchone is a norbornanone — camphor’s isomer, with the methyl groups moved — not a thujane, and it has none of thujone’s cyclopropane strain or GABA-A pharmacology. Its toxicology is its own: dose-dependent toxicity in rats at high isolated doses ^{1Reference 1Bashir A et al. · 2023AnimalFenchone, a monoterpene: toxicity and diuretic profiling in ratsView study →} and nothing at flavouring levels ^{13Reference 13Api AM et al. · 2025ReviewUpdate to RIFM fragrance ingredient safety assessment, fenchone, CAS Registry Number 1195-79-5 — safety reviewView study →}. When a herb that carries both is being judged, the seizure story belongs to the thujone.

Chirality

Fenchone is chiral, and the sign of what the plant makes and the sign of what the laboratory studied are not the same. Fennel and French lavender make (+)-fenchone — in Lavandula stoechas it was the only enantiomer detected ^{6Reference 6Tzakou O et al. · 2009Essential oil composition and enantiomeric distribution of fenchone and camphor of Lavandula cariensis and L. stoechas subsp. stoechas grown in Greece — GC-MS and chiral composition studyView study →} — and fennel builds it through a cyclase that first forms (−)-endo-fenchol, the alcohol that is then oxidised to the ketone ^{10Reference 10Croteau R et al. · 1988In vitroBiosynthesis of monoterpenesView study →}. The pharmacology, by contrast, was largely done with (−)-fenchone: the tracheal spasmolysis, the antidiarrhoeal and the duodenal-ulcer studies all dosed the (−) form ^{2,3,5Reference 2Rehman NU et al. · 2022In-silico and ex-vivo studies on the spasmolytic activities of fenchone using isolated guinea-pig tracheaView study →Reference 3Pessoa MLS et al. · 2020Antifungal activity and antidiarrheal activity via anti-motility mechanisms of (−)-fenchone in experimental modelsView study →Reference 5Araruna MEC et al. · 2024AnimalAraruna MEC, et al. (2024). (−)-Fenchone prevents cysteamine-induced duodenal ulcers and accelerates gastric-ulcer healing in rats via antioxidant and immunomodulatory mechanisms. Pharmaceuticals (Basel). https://pubmed.ncbi.nlm.nih.gov/38794211/View study →}, the enantiomer that fennel does not supply.

Two facts soften the mismatch. Human liver microsomes metabolise both enantiomers identically — the same CYP2A6/2B6 hydroxylation to the same 6-exo, 6-endo and 10-hydroxy products ^{8,9Reference 8Miyazawa M · 2006In vitroMetabolism of (+)-fenchone by CYP2A6 and CYP2B6 in human liver microsomes — in vitroView study →Reference 9Miyazawa M · 2007In vitroMetabolism of (-)-fenchone by CYP2A6 and CYP2B6 in human liver microsomes — in vitroView study →} — and human noses cannot tell them apart: fenchone was one of the enantiomer pairs subjects failed to discriminate in a blinded olfactory test ^{7Reference 7Laska M · 1999Clinical trialOlfactory discrimination ability of human subjects for ten pairs of enantiomers — human studyView study →}. Whether the two forms differ pharmacologically is simply untested.

What It's Used For

Fenchone is the bitter, camphoraceous bicyclic monoterpene ketone of fennel, making up roughly 1–23% of the essential oil (more in the bitter var. vulgare chemotype). Two identity points matter: it is distinct from fenchol (the corresponding alcohol) and — more importantly — from thujone and camphor, so their convulsant/seizure toxicity should not be imported (fenchone shows no such profile). Its evidence is thin and entirely preclinical; the best-supported and most on-brand signal is spasmolytic activity on isolated gut/airway, which grounds fennel’s traditional carminative use — though that human use is the whole seed/oil, in which trans-anethole, not fenchone, is the dominant antispasmodic.

A plausible spasmolytic contributor:relaxes isolated airway/gut smooth muscle and is antidiarrheal in mice — a mechanistic footing for fennel’s carminative reputation ^{2,3Reference 2Rehman NU et al. · 2022In-silico and ex-vivo studies on the spasmolytic activities of fenchone using isolated guinea-pig tracheaView study →Reference 3Pessoa MLS et al. · 2020Antifungal activity and antidiarrheal activity via anti-motility mechanisms of (−)-fenchone in experimental modelsView study →}.

The honest headline:no human trials of the isolate; fennel’s carminative human use is the whole herb (anethole-led), and fenchone’s rat data pair a diuretic effect with dose-dependent toxicity at high isolated doses ^{1,3Reference 1Bashir A et al. · 2023AnimalFenchone, a monoterpene: toxicity and diuretic profiling in ratsView study →Reference 3Pessoa MLS et al. · 2020Antifungal activity and antidiarrheal activity via anti-motility mechanisms of (−)-fenchone in experimental modelsView study →}.

Evidence by IndicationStrength of support · Beta

:::

Mechanisms

Target / pathway	Effect	Relevant to
Airway/gut smooth-muscle tone (Ca²⁺ handling; docking)	relaxation / spasmolysis ex vivo	spasmolyticantidiarrheal
GI transit / intestinal motility	reduced motility	antidiarrheal
Microbial membranes / biofilm; docked enzyme targets	bacteriostatic / anticandidal in vitro	antimicrobial
Mucosal oxidative stress + immunomodulation	antioxidant, ulcer prevention/healing	gastroprotection
Renal handling (mechanism undefined)	↑ urine output (rats)	diuretic

All mechanisms are preclinical, ex-vivo or in-silico; no validated human target engagement.

Pharmacokinetics

No pharmacokinetic study of fenchone in a living animal or person has been published — no absorption, half-life or exposure figure exists — and the general picture is inferred from physicochemistry: a small, volatile, lipophilic bicyclic ketone, rapidly absorbed, widely distributed and quickly cleared, with low sustained systemic exposure from dietary or aromatic use. Its metabolism, however, is characterised. In human liver microsomes both (+)- and (−)-fenchone are hydroxylated to 6-exo-hydroxyfenchone, 6-endo-hydroxyfenchone and 10-hydroxyfenchone, chiefly by CYP2A6, with CYP2B6 contributing; of eleven recombinant human P450s tested only those two were active, and menthofuran and thioTEPA inhibited the reaction ^{8,9Reference 8Miyazawa M · 2006In vitroMetabolism of (+)-fenchone by CYP2A6 and CYP2B6 in human liver microsomes — in vitroView study →Reference 9Miyazawa M · 2007In vitroMetabolism of (-)-fenchone by CYP2A6 and CYP2B6 in human liver microsomes — in vitroView study →}. Nothing in that pathway generates a reactive or neurotoxic metabolite — the contrast with thujone is metabolic as well as structural. Because CYP2A6 is the nicotine- and coumarin-metabolising enzyme and is polymorphic, fenchone clearance is likely to vary between people, but no interaction has been documented.

Clinical Trials

There are no human trials of isolated fenchone for any indication, and none registered. Fennel’s carminative and gastrointestinal human evidence pertains to the whole seed, oil or extract — where fenchone is a minor constituent beside dominant trans-anethole — and cannot be attributed to fenchone.

Completed	Planned	Terminated	Preclinical
None	None known	None	Modest

Last checked: September 2026.

Isolate vs. Plant Studies

Fenchone’s isolate file is small but genuinely the molecule: the rat toxicity and diuretic profile ^{1Reference 1Bashir A et al. · 2023AnimalFenchone, a monoterpene: toxicity and diuretic profiling in ratsView study →}, the guinea-pig tracheal spasmolysis ^{2Reference 2Rehman NU et al. · 2022In-silico and ex-vivo studies on the spasmolytic activities of fenchone using isolated guinea-pig tracheaView study →}, the mouse antidiarrhoeal and antifungal work ^{3Reference 3Pessoa MLS et al. · 2020Antifungal activity and antidiarrheal activity via anti-motility mechanisms of (−)-fenchone in experimental modelsView study →}, the in-vitro antimicrobial and docking study ^{4Reference 4Ahmad W et al. · 2022Antibacterial, anticandidal and antibiofilm potential of fenchone: in-vitro, molecular docking and in-silico/ADMET studyView study →} and the rat ulcer study ^{5Reference 5Araruna MEC et al. · 2024AnimalAraruna MEC, et al. (2024). (−)-Fenchone prevents cysteamine-induced duodenal ulcers and accelerates gastric-ulcer healing in rats via antioxidant and immunomodulatory mechanisms. Pharmaceuticals (Basel). https://pubmed.ncbi.nlm.nih.gov/38794211/View study →} all used pure fenchone — three of them the (−) enantiomer — and the human data, such as they are, are liver-microsome metabolism ^{8,9Reference 8Miyazawa M · 2006In vitroMetabolism of (+)-fenchone by CYP2A6 and CYP2B6 in human liver microsomes — in vitroView study →Reference 9Miyazawa M · 2007In vitroMetabolism of (-)-fenchone by CYP2A6 and CYP2B6 in human liver microsomes — in vitroView study →} and an olfactory test ^{7Reference 7Laska M · 1999Clinical trialOlfactory discrimination ability of human subjects for ten pairs of enantiomers — human studyView study →}. No whole-animal study of the (+) form fennel actually contains has been found.

The plant side belongs to other molecules. Fennel’s human carminative and galactagogue literature is the seed and its oil, in which trans-anethole runs 35–82% and fenchone 2–23% ^{11Reference 11Raal A et al. · 2012Essential oil composition of Foeniculum vulgare Mill. fruits from pharmacies in different countries — GC composition studyView study →}; Thuja and wormwood effects are thujone’s; French lavender’s are camphor’s and fenchone’s together ^{6Reference 6Tzakou O et al. · 2009Essential oil composition and enantiomeric distribution of fenchone and camphor of Lavandula cariensis and L. stoechas subsp. stoechas grown in Greece — GC-MS and chiral composition studyView study →}. The honest framing is that fenchone is a plausible spasmolytic contributor to fennel with a modest preclinical file, not fennel’s active, and that its most interesting human-relevant fact is what it is not.

Its Role in Plants

Fenchone is made from geranyl diphosphate through an unusually well-studied enzyme: the fennel (−)-endo-fenchol cyclase, which isomerises the substrate to linalyl diphosphate and cyclises it, at one active site, to the bicyclic alcohol; the stereochemistry of every step was worked out in the 1980s and made fenchol cyclase a model for how monoterpene cyclases work ^{10Reference 10Croteau R et al. · 1988In vitroBiosynthesis of monoterpenesView study →}. Oxidation of the alcohol gives fenchone. Lavenders carry their own (−)-endo-fenchol synthases, whose expression pattern decides which species are fenchone-rich ^{14Reference 14Liu D et al. · 2026The (-)-endo-fenchol synthases from three species of lavender: predicted structural models and multilevel regulation of gene expression — plant molecular biologyView study →}.

The ketone is a bitter defence. In bitter fennel it is the flavour that deters casual browsing, and it separates the two commercial chemotypes: sweet fennel, bred for anethole, has almost none; bitter fennel, closer to the wild plant, carries a fifth of its oil as fenchone ^{11Reference 11Raal A et al. · 2012Essential oil composition of Foeniculum vulgare Mill. fruits from pharmacies in different countries — GC composition studyView study →}. In Thuja it joins thujone in a ketone fraction that makes up more than half the leaf oil, one of the most heavily defended foliage oils among conifers ^{12Reference 12Tsiri D et al. · 2009In vitroChemosystematic value of the essential oil composition of Thuja species cultivated in Poland-antimicrobial activity — GC-MS composition and in vitro studyView study →}.

Prevalence in Nature

Fenchone dominates in a few oils and is a minor ketone in many. Bitter fennel fruit oil carries 21–23% and sweet fennel under 2%, with commercial pharmacy samples spanning 1.6–22.8% between the two ^{11Reference 11Raal A et al. · 2012Essential oil composition of Foeniculum vulgare Mill. fruits from pharmacies in different countries — GC composition studyView study →}; French lavender (Lavandula stoechas) inflorescence oil runs ~40% fenchone with camphor second, the leaf ~21% ^{6Reference 6Tzakou O et al. · 2009Essential oil composition and enantiomeric distribution of fenchone and camphor of Lavandula cariensis and L. stoechas subsp. stoechas grown in Greece — GC-MS and chiral composition studyView study →}; Thuja leaf oils hold it as a main constituent beside α- and β-thujone ^{12Reference 12Tsiri D et al. · 2009In vitroChemosystematic value of the essential oil composition of Thuja species cultivated in Poland-antimicrobial activity — GC-MS composition and in vitro studyView study →}; wormwood, cedar and some other Artemisia oils carry a few percent. Chemotype, plant part and fruit maturity drive the fennel figure more than origin does ^{11Reference 11Raal A et al. · 2012Essential oil composition of Foeniculum vulgare Mill. fruits from pharmacies in different countries — GC composition studyView study →}.

Major Natural Sources

Source	Plant part	Reported fenchone content
French lavender (Lavandula stoechas subsp. stoechas)	inflorescence oil	39.9% (leaf 21.0%); (+)-fenchone only ^{6Reference 6Tzakou O et al. · 2009Essential oil composition and enantiomeric distribution of fenchone and camphor of Lavandula cariensis and L. stoechas subsp. stoechas grown in Greece — GC-MS and chiral composition studyView study →}
Bitter fennel (Foeniculum vulgare var. vulgare)	fruit oil	21–23% ^{11Reference 11Raal A et al. · 2012Essential oil composition of Foeniculum vulgare Mill. fruits from pharmacies in different countries — GC composition studyView study →}
Sweet fennel (F. vulgare var. dulce)	fruit oil	~1.6% ^{11Reference 11Raal A et al. · 2012Essential oil composition of Foeniculum vulgare Mill. fruits from pharmacies in different countries — GC composition studyView study →}
Thuja occidentalis and T. plicata	leaf oil	a main constituent within a 54–69% ketone fraction shared with thujone ^{12Reference 12Tsiri D et al. · 2009In vitroChemosystematic value of the essential oil composition of Thuja species cultivated in Poland-antimicrobial activity — GC-MS composition and in vitro studyView study →}

All figures are shares of the essential oil.

Other Reported Sources

Wormwood (Artemisia absinthium) — a minor ketone beside thujone
Cedar-leaf and other cupressaceous oils
Lavandula cariensis and other camphor-type lavenders, in small amounts ^{6Reference 6Tzakou O et al. · 2009Essential oil composition and enantiomeric distribution of fenchone and camphor of Lavandula cariensis and L. stoechas subsp. stoechas grown in Greece — GC-MS and chiral composition studyView study →}

Discovery & Synthesis

Fenchone was characterised from fennel oil in the 1890s by Otto Wallach, who named it for the plant (German Fenchel) and recognised it as an isomer of camphor; establishing which isomer took the rearrangement chemistry of the following decades, and the fenchone skeleton became a classic case of the Wagner–Meerwein rearrangements that terpene chemistry is built on. Its biosynthesis was later dissected in equal detail by Croteau’s laboratory, which made fennel’s fenchol cyclase a model monoterpene cyclase ^{10Reference 10Croteau R et al. · 1988In vitroBiosynthesis of monoterpenesView study →}.

Commercial fenchone is made by oxidising fenchol, itself obtained from turpentine-derived α-pinene; natural fenchone is fractionated from bitter-fennel oil for flavour use. Volumes are small. It is used to give a camphoraceous-bitter note in flavours and fragrances, and (−)-fenchone is sold as a chiral building block and research chemical — which is why so much of the pharmacology used that enantiomer.

Patents: not yet researched.

Toxicity & Safety

Fenchone is a normal part of eating fennel and carries none of thujone’s or camphor’s neurotoxicity — but it is not innocuous at high isolated doses, where rat work found a dose-dependent toxicity profile alongside its diuretic effect.

Safety at a Glance

Low / no toxicity

A GRAS flavoring and normal dietary constituent. Used at low food and beverage levels, and a routine component of fennel.
No thujone- or camphor-type neurotoxicity. No GABA-A-antagonist convulsant activity and no ingestion-seizure toxicity is reported — neither profile should be imported.
Dose-dependent toxicity at high isolated doses. The anchor rat study characterized this alongside the diuretic effect; it is not innocuous in quantity.
Undiluted oil irritates. As with all essential-oil terpenoid ketones, neat oil can irritate skin and mucosa and is not for internal use concentrated.

Full Safety & Interactions Detail

Fenchone is a GRAS flavoring agent used at low food/beverage levels and a normal dietary constituent of fennel. The anchor rat study characterized a dose-dependent toxicity profile alongside its diuretic effect ^{1Reference 1Bashir A et al. · 2023AnimalFenchone, a monoterpene: toxicity and diuretic profiling in ratsView study →} — i.e. it is not innocuous at high isolated doses — but this signature is distinct from the neurotoxic profiles of related monoterpene ketones: there is no evidence of thujone-type GABA-A-antagonist convulsant activity, and no camphor-type ingestion-seizure toxicity is reported for fenchone, so neither should be imported. As with all essential-oil terpenoid ketones, undiluted oil can irritate skin and mucosa and is not for internal use in concentrated form. Fenchone is a GRAS dietary flavour constituent at the levels people actually encounter, and high isolated doses showed toxicity in rodents — both are true, and the difference between them is the dose. The 2025 RIFM fragrance-ingredient safety assessment update concluded fenchone is safe at current fragrance use levels for the endpoints it evaluates ^{13Reference 13Api AM et al. · 2025ReviewUpdate to RIFM fragrance ingredient safety assessment, fenchone, CAS Registry Number 1195-79-5 — safety reviewView study →}.

No fenchone-specific reproductive-toxicity study was located. Culinary fennel is a long-standing dietary exposure; concentrated fennel essential oil and isolated monoterpene-ketone exposure have not been assessed, and the general caution around essential-oil ketones rests on the class rather than on data for this molecule.

Dosage

There is no established human dose for isolated fenchone, and it is not used as a standalone supplement. Human exposure occurs as a minor constituent (~1–23% of fennel essential oil, higher in bitter var. vulgare chemotypes) within culinary fennel and fennel-oil preparations. Preclinical activity was seen at experimental rodent/in-vitro doses that do not translate to a human recommendation, and no dosage is offered. These are doses studied in research and are not a personal recommendation.

References

Bashir A, et al. (2023). Fenchone, a monoterpene: toxicity and diuretic profiling in rats. Frontiers in Pharmacology. https://pubmed.ncbi.nlm.nih.gov/36778012/
Rehman NU, et al. (2022). In-silico and ex-vivo studies on the spasmolytic activities of fenchone using isolated guinea-pig trachea. Molecules. https://pubmed.ncbi.nlm.nih.gov/35209147/
Pessoa MLS, et al. (2020). Antifungal activity and antidiarrheal activity via anti-motility mechanisms of (−)-fenchone in experimental models. World Journal of Gastroenterology. https://pubmed.ncbi.nlm.nih.gov/33268962/
Ahmad W, et al. (2022). Antibacterial, anticandidal and antibiofilm potential of fenchone: in-vitro, molecular docking and in-silico/ADMET study. Plants (Basel). https://pubmed.ncbi.nlm.nih.gov/36145798/
Araruna MEC, et al. (2024). (−)-Fenchone prevents cysteamine-induced duodenal ulcers and accelerates gastric-ulcer healing in rats via antioxidant and immunomodulatory mechanisms. Pharmaceuticals (Basel). https://pubmed.ncbi.nlm.nih.gov/38794211/
Tzakou O, Bazos I, Yannitsaros A (2009). Essential oil composition and enantiomeric distribution of fenchone and camphor of Lavandula cariensis and L. stoechas subsp. stoechas grown in Greece — GC-MS and chiral composition study. Nat Prod Commun. https://pubmed.ncbi.nlm.nih.gov/19768993/
Laska M, Teubner P (1999). Olfactory discrimination ability of human subjects for ten pairs of enantiomers — human study. Chem Senses. https://pubmed.ncbi.nlm.nih.gov/10321817/
Miyazawa M, Gyoubu K (2006). Metabolism of (+)-fenchone by CYP2A6 and CYP2B6 in human liver microsomes — in vitro. Biol Pharm Bull. https://pubmed.ncbi.nlm.nih.gov/17142962/
Miyazawa M, Gyoubu K (2007). Metabolism of (-)-fenchone by CYP2A6 and CYP2B6 in human liver microsomes — in vitro. Xenobiotica. https://pubmed.ncbi.nlm.nih.gov/17484521/
Croteau R, Satterwhite DM, Wheeler CJ, et al. (1988). Biosynthesis of monoterpenes. Stereochemistry of the enzymatic cyclization of geranyl pyrophosphate to (-)-endo-fenchol — enzyme characterisation, in vitro. J Biol Chem. https://pubmed.ncbi.nlm.nih.gov/3170591/
Raal A, Orav A, Arak E (2012). Essential oil composition of Foeniculum vulgare Mill. fruits from pharmacies in different countries — GC composition study. Nat Prod Res. https://pubmed.ncbi.nlm.nih.gov/21827282/
Tsiri D, Graikou K, Pobłocka-Olech L, et al. (2009). Chemosystematic value of the essential oil composition of Thuja species cultivated in Poland-antimicrobial activity — GC-MS composition and in vitro study. Molecules. https://pubmed.ncbi.nlm.nih.gov/19935470/
Api AM, Bartlett A, Belsito D, et al. (2025). Update to RIFM fragrance ingredient safety assessment, fenchone, CAS Registry Number 1195-79-5 — safety review. Food Chem Toxicol. https://pubmed.ncbi.nlm.nih.gov/40409662/
Liu D, Li N, Deng H, et al. (2026). The (-)-endo-fenchol synthases from three species of lavender: predicted structural models and multilevel regulation of gene expression — plant molecular biology. Physiol Mol Biol Plants. https://pubmed.ncbi.nlm.nih.gov/41675608/